IN THIS ISSUE

Larry Beresford
Health plan efforts include identifying at-risk members and prescribers who write an unusually large number of opioid prescriptions.
Legislation & Regulation
Richard Mark Kirkner
The Lone Star State may be a lone wolf when it comes to regulating virtual visits.
Medication Management
Thomas Reinke

Bret Yarczower, MD

Generics for other diseases have upended formularies, but the effect of generic Copaxone may be limited.
Medical Device Monitor
Katherine T. Adams
A low bar for market entry leaves health plans unsure of the value of devices. Adding a unique identifier for each product could help with decision making.
Snapshot

Not only did the number of infants with neonatal abstinence syndrome increase dramatically from 2004 to 2013, but the proportion of NICU days devoted to caring for those infants increased to 4% in 2013 from just 0.6% in 2004, according to a study in the New England Journal of Medicine.

Tomorrow's Medicine
Thomas Morrow, MD
The investigational product coaxes the immune system into attacking the deadliest skin cancer. But can we afford these expensive cancer drugs?